Dabrafenib plus trametinib in BRAF K601E‐mutant melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dabrafenib plus trametinib in BRAF K601E‐mutant melanoma

Published:2018-11-22 Issue:2 Volume:180 Page:421-422
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Rogiers A.¹²^ORCID,Thomas D.³,Vander Borght S.⁴⁵,Oord J.J.⁵,Bechter O.⁶,Dewaele M.¹²,Rambow F.¹²,Marine J.‐C.¹²,Wolter P.⁷

Affiliation:

1. Laboratory for Molecular Cancer Biology Center for Cancer Biology VIB LeuvenBelgium

2. Laboratory for Molecular Cancer Biology Department of Oncology KU Leuven LeuvenBelgium

3. Laboratory for Therapeutic and Diagnostic Antibodies/PharmAbs KU Leuven LeuvenBelgium

4. Department of Human Genetics Center for Human Genetics KU Leuven LeuvenBelgium

5. Department of Pathology University Hospitals KU Leuven Leuven Belgium

6. Department of General Medical Oncology KU Leuven Leuven Belgium

7. Department of Hematology and Medical Oncology CHR East Belgium Verviers Belgium

Funder

Kom op tegen Kanker

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.17250

Reference8 articles.

1. Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma

2. Clinicopathological characteristics associated with BRAFK601Eand BRAFL597mutations in melanoma

3. Activity of trametinib in K601E and L597Q BRAF mutation-positive metastatic melanoma

4. An Integrated Model of RAF Inhibitor Action Predicts Inhibitor Activity against Oncogenic BRAF Signaling

5. Trough dabrafenib plasma concentrations can predict occurrence of adverse events requiring dose reduction in metastatic melanoma

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges in the treatment of BRAF K601E-mutated lung carcinoma: a case report of rapid response and resistance to dabrafenib and trametinib;Frontiers in Oncology;2024-07-08

2. Clinicogenomic Features and Targetable Mutations in NSCLCs Harboring BRAF Non-V600E Mutations: A Multi-Institutional Genomic Screening Study (LC-SCRUM-Asia);Journal of Thoracic Oncology;2023-11

3. Non-V600E/K BRAF Mutations in Metastatic Melanoma: Molecular Description, Frequency, and Effectiveness of Targeted Therapy in a Large National Cohort;JCO Precision Oncology;2022-11

4. Clinical characteristics and treatment outcomes of non-V600 E/K BRAF mutant melanoma patients: a single-institution experience;Melanoma Research;2022-08-29

5. The Role of Histology-Agnostic Drugs in the Treatment of Metastatic Castration-Resistant Prostate Cancer;International Journal of Molecular Sciences;2022-08-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3